News Daily News Study Supports Cost-effectiveness of Renal Denervation for Hypertension Todd Neale August 23, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Daily News Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term L.A. McKeown March 31, 2023
News Conference News AHA 2022 In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE Todd Neale November 05, 2022
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News ESC 2020 ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA Michael O'Riordan September 01, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Daily News SMASH: Population-Based Sodium Reduction Sees Success in China L.A. McKeown April 28, 2020
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Daily News RAS Inhibition After TAVR Gains More Support, but RCT Still Needed Todd Neale July 29, 2019
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Daily News Ronald G. Victor, Who Brought Hypertension Treatment Into the Barbershop, Dead at 66 Todd Neale September 14, 2018
News Daily News Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers Yael L. Maxwell January 24, 2018
News Conference News ACC 2016 EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI Caitlin E. Cox April 03, 2016
News Daily News Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence Leah Lawrence August 30, 2015